FDA Inspection 1316804 — Emory Reproductive Center

Emory Reproductive Center — FEI 3003935810

The FDA completed an inspection of Emory Reproductive Center on April 28, 2026 in Atlanta, GA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
April 28, 2026
Fiscal Year
2026
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Atlanta, GA (United States)